Related Experiment Video
Updated: Jan 5, 2026

09:03
Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing
Published on: May 10, 2020
4.5K
CRISPR/Cas9-Based Genome Editing of HSV
Thilaga Velusamy1, Anjali Gowripalan1, David C Tscharke2
1John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
Methods in Molecular Biology (Clifton, N.J.)
|October 17, 2019
Summary
This study presents an efficient CRISPR/Cas9 gene editing method for the HSV-1 genome, enabling both marker-based and marker-free modifications. The flexible technique allows for precise nucleotide changes, large deletions, and insertions in the viral genome.
Area of Science:
- Molecular Biology
- Virology
- Gene Editing
Background:
- The CRISPR/Cas9 system offers powerful genome engineering capabilities across diverse organisms.
- Large double-stranded DNA (dsDNA) viruses, such as HSV-1, present unique challenges for genetic manipulation.
- Efficient and flexible editing tools are crucial for studying viral genomes and developing therapeutic strategies.
Purpose of the Study:
- To develop and present an efficient methodology for CRISPR/Cas9-mediated genome editing of the Herpes Simplex Virus type 1 (HSV-1).
- To enable both marker-based and marker-free genetic modifications of the HSV-1 genome.
- To demonstrate the versatility of the developed method for various types of genomic alterations.
Main Methods:
- Co-transfection of plasmids encoding Cas9, guide RNAs, and a homology-directed repair template into host cells.
- Introduction of the HSV-1 genome into the edited cells via viral infection.
- Application of the CRISPR/Cas9 system for precise nucleotide alterations, insertions, and deletions within the HSV-1 genome.
Main Results:
- Successful implementation of an efficient methodology for CRISPR/Cas9 gene editing of the HSV-1 genome.
- Demonstration of both marker-based and marker-free editing capabilities.
- Facilitation of a wide range of genomic modifications, from single nucleotide changes to large insertions and deletions.
Conclusions:
- The presented methodology provides a flexible and efficient approach for engineering the HSV-1 genome.
- This tool significantly advances the study of HSV-1 biology and opens avenues for therapeutic development.
- CRISPR/Cas9 gene editing is a powerful strategy for manipulating large dsDNA viral genomes.
Related Concept Videos
CRISPR/Cas9 Genome Editing
1.5K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.5K
CRISPR
57.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.3K
Homologous Recombination
62.2K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
62.2K
CRISPR and crRNAs
18.6K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.6K

